Tevogen grants performance-based restricted stock to CEO and CFO tied to $1 billion revenue goal
The awards to Ryan Saadi and Kirti Desai vest only if Tevogen hits $1.0 billion in aggregate revenue by September 30, 2031.
SEC filing
Latest
2 stories
Wednesday, September 16
Wednesday, August 26
Tevogen holders reelect two directors, back KPMG and charter changes at annual meeting
Tevogen Inc. shareholders approved an equity plan expansion and a governance change allowing action by written consent, per an 8-K filed for the August 24, 2026 meeting.
SEC filing